Navigation Links
Can you hear me now? I'm podcasting

With a little bit of effort and a microphone, you can use podcasting to talk with millions of people. They key is creating something that is worth listening to.

The term "podcasting" surfaced in 2004 when early-adopters combined the words "iPod" and "broadcasting." Podcast listeners typically download audio files in MP3 format onto a computer and transfer th......

Full article >>> atures are built into Apple's I-tunes software, independent podcasts now appear in the Apple Music store next to podcasts from Major ESPN, Disney, Fox and others.

If you're interested in podcasting your own content, There are several websites that can teach you the basic mechanics of recording and distributing a podcast. However, be aware that a good podcast is harder to maintain than a ......

Full article >>> subscribed to will be the same from show to show. And, that shows will be added at regular intervals.

Wisconsin podcaster Chuck Tomasi recommends that podcasters record five to six shows and listen to them first before going public. It usually takes that long, he said, for prodcasters to establish a broadcast format, personality and rhythm.

Tomasi encourages businesses to ex......

Full article >>>
'"/>

Source:wistechnology.com By Troy Janisch 09/02/05


Related biology technology :

1. Low Abundance cDNA Cloned Using Stratagenes Human Universal cDNA Library
2. Stratagenes Human cDNA Microarrays: Perform Gene Expression Profiling and Discover New Genes
3. Stratagene to pay Third Wave $10.75M in patent case
4. Stratagene sets aside $21M to pay Third Wave pending appeal
5. Stratagene files patent suit against Third Wave
6. Third Wave files patent infringement suit against Stratagene
7. Simplicity appeals to CIOs, but its no easy task
8. Wireless networking appeals to cities around Milwaukee
9. Shorter name appeals to more online visitors for Madison firm
10. Third Wave files countersuit vs. Digene in patent case
11. Third Wave reports net loss of $18.9M for 2006
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/12/2016)... , Feb. 12, 2016  PTC Therapeutics, Inc. ... annual STRIVE (Strategies to Realize Innovation, Vision and ... (DMD). STRIVE provides funds to patient advocacy organizations ... make meaningful contributions to the rare disease community ... of future patient advocates. Mary ...
(Date:2/11/2016)... and GERMANTOWN, Maryland , ... Frankfurt Prime Standard: QIA) today announced the introduction of ... gene expression profiling, expanding QIAGEN,s portfolio of Sample to ... researchers to select from over 20,000 human genes and ... between genes, cellular phenotypes and disease processes. --> ...
(Date:2/11/2016)... 2016  Dovetail Genomics™ LLC today announced that it ... a planned metagenomic genome assembly service. Richard Green ... assembly method in a talk on Friday, February 12 ... conference in Orlando, Fla. ... is difficult. Using its proprietary Chicago ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... of its new stem cell treatment clinic in Quito, Ecuador. The new facility ... and trauma applications to patients from around the world. , The new ...
Breaking Biology Technology:
(Date:2/2/2016)... Checkpoint Inhibitors for Cancer – Explore ... you interested in the future of cancer drugs? ... Visiongain,s report gives those predictions to 2026 at ... Avoid falling behind in data or losing ... those emerging cancer therapies can achieve. There you ...
(Date:2/1/2016)... 1, 2016  Today, the first day of American ... to develop a first of its kind workplace health ... Watson. In the first application of Watson ... IBM ), and Welltok will create a new offering ... cognitive analytics, delivered on Welltok,s health optimization platform. The ...
(Date:1/25/2016)... 2016  Glencoe Software, the world-leading supplier of image ... will provide the data management solution OMERO Plus for ... Photo - ... Phenotypic analysis measures the characteristics and behavior ... between states such as health and disease, the presence ...
Breaking Biology News(10 mins):